We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-12.08%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.39B
AUM Growth
-$257M
Cap. Flow
-$58.2M
Cap. Flow %
-4.2%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$58.2M

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.39B 100%
25,988,799
-1,095,726
-4% -$58.2M

Similar funds

Crestline Management's Q2 2015 Portfolio in Review

As of Q2 2015, Crestline Management held 1 position worth $1.39B, down 16% from $1.64B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Crestline Management withdrew a net $58.2M in Q2 2015, reducing 1 holding. Its largest reduction was Juno Therapeutics, Inc., cutting an estimated $58.2M.

  • Crestline Management's biggest Q2 2015 reduction was Juno Therapeutics, Inc., cutting an estimated $58.2M.
  • Crestline Management's ten largest holdings make up 100% of its $1.39B portfolio in Q2 2015.
  • Crestline Management opened 0 new positions and closed 0 in Q2 2015.
  • Crestline Management's portfolio value fell 16% quarter-over-quarter to $1.39B.

Based on Crestline Management's 13F filing for Q2 2015, filed 17 Jul 2015.